Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder

NCT03078075 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

403

Enrollment

OTHER

Sponsor class

Conditions

Methamphetamine Use Disorder

Interventions

DRUG: Naltrexone: Vivitrol®
DRUG: Placebo (PLB) Injectable
DRUG: Bupropion: Wellbutrin XL®
DRUG: Placebo (PLB) Oral

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]
[object Object]